Market Access News | pharmaphorum

News

Lilly doubles down on Irish plant, ups spend to near $1bn

Eli Lilly's close ties to Ireland’s pharma manufacturing sector have just got even stronger, after the US pharma announced plans to double its planned investment in a new

News

FDA eyes shake-up of swift approval pathway in cancer

Regulator wants more use of randomised controlled trials rather than open-label studies.

News

Pharming brings first drug for rare disease APDS to US

Joenja will launch in April and could make upwards of $200m a year in sales, say analysts.

News

Better slashes staff in another digital health retreat

Company will cut its headcount by 35%, as it waits for an FDA decision on its diabetes DTx.

News

PTC’s gene therapy for rare disease cleared for NHS use

Upstaza has shown impressive clinical results in children with fatal disorder AADC deficiency.

News

Rezzayo antifungal okayed as Candida auris rings alarm bells

Drug is first new echinocandin to be approved for marketing in the US in more than a decade.

Lilly doubles down on Irish plant, ups spend to near $1bn

FDA eyes shake-up of swift approval pathway in cancer

Pharming brings first drug for rare disease APDS to US

Better slashes staff in another digital health retreat

PTC’s gene therapy for rare disease cleared for NHS use

Rezzayo antifungal okayed as Candida auris rings alarm bells

Simple blood test could aid in global TB fight

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks